“No study has previously examined the non-inferiority of the 9vHPV vaccine among 15- to 26-year-olds. Thus, our findings are beginning to fill an important gap of knowledge within the medical field,” said lead researcher Dr. Abbey Berenson, a UTMB professor within the department of OB/GYN and director of the UTMB Center for Interdisciplinary Research in Women’s Health. “This study was designed to fill that gap of knowledge.”